Home
Capital Research Global Investors reported a 5.4% stake in Alnylam Pharmaceuticals ALNY · 6,968,513 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.4%
- Last report
- First report
- Shares held
- 6,968,513 sh
- Class
- Common Stock
- Event date
- 24/12/31
- Filed
- 25/02/13
First 5%+ report · 5.4% stake
Alnylam Pharmaceuticals trades, last 26 weeks
What else happened in Alnylam Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 24/12/01~25/01/30Capital Research Global Investors's other 5% stake reports
- Capital Research Global Investors
5% stakePatria Investments
5% stakePatria Investments
PAX
0% stake
0 sh
0% stake
Filed 09/04
- Capital Research Global Investors
5% stakeBBB Foods
5% stakeBBB Foods
TBBB
7% stake
5,422,899 sh
7% stake
Filed 08/12
- Capital Research Global Investors
5% stakeQuantinuum
5% stakeQuantinuum
QNT
5.3% stake
1,754,325 sh
5.3% stake
Filed 08/12
- Capital Research Global Investors
5% stakeXPO
5% stakeXPO
XPO
7% stake
8,271,824 sh
7% stake
Filed 08/12
- Capital Research Global Investors
5% stakeDominion Energy
5% stakeDominion Energy
D
8.4% stake
73,865,685 sh
8.4% stake
Filed 08/12
